SUVEN LIFE SCIENCES
Back to Balance Sheet
|
SUVEN LIFE SCIENCES Last 5 Year Total Non-Current Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹1.35 Cr | ₹2.46 Cr | ₹3.58 Cr | ₹4.50 Cr | ₹12 Cr |
What is the latest Total Non-Current Liabilities ratio of SUVEN LIFE SCIENCES ?
Year | Total Non-Current Liabilities |
---|---|
Mar2024 | ₹1.35 Cr |
Mar2023 | ₹2.46 Cr |
Mar2022 | ₹3.58 Cr |
Mar2021 | ₹4.50 Cr |
Mar2020 | ₹12 Cr |
How is Total Non-Current Liabilities of SUVEN LIFE SCIENCES Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹1.35 Cr | -45.33 | |
Mar2023 | ₹2.46 Cr | -31.13 | |
Mar2022 | ₹3.58 Cr | -20.61 | |
Mar2021 | ₹4.50 Cr | -62.70 | |
Mar2020 | ₹12 Cr | - |
Compare Total Non-Current Liabilities of peers of SUVEN LIFE SCIENCES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SUVEN LIFE SCIENCES | ₹6,272.2 Cr | -5.1% | 15.5% | 99.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹408,595.0 Cr | 1.5% | 0.9% | 2% | Stock Analytics | |
DIVIS LABORATORIES | ₹174,635.0 Cr | -0.5% | -1.2% | 45.5% | Stock Analytics | |
CIPLA | ₹126,894.0 Cr | 7.2% | 4.5% | 2.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹122,685.0 Cr | 3.5% | 8.4% | 16.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹107,373.0 Cr | 3.7% | -1.1% | -6.8% | Stock Analytics |
SUVEN LIFE SCIENCES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SUVEN LIFE SCIENCES | -5.1% |
15.5% |
99.3% |
SENSEX | -1.6% |
-3.4% |
0.9% |
You may also like the below Video Courses